A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment (MCI)

This study is currently recruiting participants.

Verified March 2012 by Avraham Pharmaceuticals Ltd

Sponsor:

Information provided by (Responsible Party):

Avraham Pharmaceuticals Ltd

ClinicalTrials.gov Identifier:

NCT01429623

First received: September 3, 2011

Last updated: March 4, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2016
Estimated Primary Completion Date:	December 2015 (Final data collection date for primary outcome measure)